The National Biological Laboratory, alongside its sister unit, the National Chemical Laboratory, is Israel's definitive diagnostic facility for detecting and identifying various biological threat agents, isolation of viruses and viral components enabled the first identification of viruses in Israel, including Zika and Camelpox . The indentification of such agents can have profound national and economic consequences. Therefore, rapid and reliable diagnosis is crucial. In order to achieve this goal, this state-of-the-art laboratory is constantly developing diverse sensitive and robust assays designed to identify and confirm threat agents, both known and unknown.
These constantly-evolving technologies encompass different diagnostic disciplines, including cutting-edge genetic, immune-based and morphological tests, developed in collaboration with the various research groups in the institute. In addition to the constant vigilance in monitoring for threat agents, these technologies have been recently used successfully to identify the first Zika patients in Israel (REF1), as well as to identify the first documented specimen of the Camelpox virus (CMLV) detected in domestic livestock.
We welcome you to contact us for any question or offer for collaborations.
There are some errors in your form.
the mail is recived, thank you